PTGX · Protagonist Therapeutics, Inc · Webcasts, Transcripts & Audio
$127.16
+2.49 (+2.00%)
At close · Nov 18
Return incl. dividend (before tax)
Q4 2020 earnings call transcript
Market Cap
$8.30B
Shares
65.27M
Volume · Nov 18
433.18K
Avg daily vol (3M)
666.83K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Protagonist Therapeutics, Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Protagonist Therapeutics, Inc (PTGX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-17
Protagonist Therapeutics, Inc (PTGX) November 17, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-10
Protagonist Therapeutics, Inc (PTGX) November 10, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Investor Update
Investor event
2026-11-09
Protagonist Therapeutics, Inc (PTGX) November 9, 2026 Investor Update
No reported result — non-financial event
Audio
Transcript
Slides
Investor Update
Investor event
2026-11-06
Protagonist Therapeutics, Inc (PTGX) November 6, 2026 Investor Update
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-10
Protagonist Therapeutics, Inc (PTGX) September 10, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Capital Markets Day
Investor event
2026-09-08
Protagonist Therapeutics, Inc (PTGX) September 8, 2026 Capital Markets Day
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-05
Protagonist Therapeutics, Inc (PTGX) Q2 2026 Earnings Call
Revenue
$213.47M
▲ 3749.2% YoY Diluted EPS
$2.29
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
Protagonist Therapeutics, Inc (PTGX) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-12
Protagonist Therapeutics, Inc (PTGX) March 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-08-06
Protagonist Therapeutics, Inc (PTGX) Q2 2025 Earnings Call
Revenue
$5.55M
▲ 33.1% YoY Diluted EPS
$-0.55
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Protagonist Therapeutics, Inc (PTGX) Q1 2025 Earnings Call
Revenue
$28.32M
▼ 88.9% YoY Diluted EPS
$-0.19
▼ 105.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-21
Protagonist Therapeutics, Inc (PTGX) Q4 2024 Earnings Call
Revenue
$170.64M*
▲ 184.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q4
2021-03-10
Protagonist Therapeutics, Inc (PTGX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q1
2020-05-07
Protagonist Therapeutics, Inc (PTGX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Protagonist Therapeutics, Inc (PTGX) Q4 2019 Earnings Call
Revenue
$2.72M
▲ 15.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–15 of 15 webcasts
Key facts
CIK
1377121
CUSIP
74366E102
13F (30d)
382 filings
356 filers
Visit website
Investor relations